Is Incandor profitable?

No revenue or profitability data exists for Incandor. It is a pre-seed YC Winter 2026 (P26) startup with no disclosed pricing model, no named customers, and no independent revenue figures as of its May 2026 public launch.

Who are Incandor's biggest competitors?

BioCatch, Sardine, Feedzai, Featurespace, SEON and Sift all offer overlapping behavioral biometrics or device intelligence for fraud detection. BioCatch was ranked a leader in QKS Group's SPARK Matrix and shipped DeviceIQ in 2025, well ahead of Incandor's May 2026 launch.

Could AI replace Incandor's product?

Not directly, since behavioral telemetry itself is not AI-replaceable, but generative AI (deepfakes, browser automation, bot farms) actively spoofs behavioral biometrics, and agentic AI, per EY's July 2026 report, threatens to commoditize the downstream fraud-ops workflow Incandor targets.

Incandor is privately founder-owned, co-founded by two Stanford graduates, Matthew Yekell and a co-founder known as Luc, backed by Y Combinator (Winter 2026 batch, P26). No external VC investors or valuation have been publicly disclosed as of the May 2026 launch.

Does Incandor have any paying customers?

No named customer logos, contracts, or revenue signals have been publicly reported. The company's YC launch describes targeting Chief Risk Officers and CTOs at Series A-E fintechs, suggesting it is still in early outbound sales as of May 2026.

What makes Incandor different from BioCatch or Sardine?

Incandor claims a composable, programmable API, label-free cold-start detection using unsupervised clustering, and duress/coercion detection for coerced transactions. These are feature-level claims, unverified by third parties, versus incumbents with 15 years of consortium data accumulation.

YC Spring 2026 · United States

Incandor

Pre-seed startup selling behavioral biometrics APIs to catch fraud and account takeover.

Little protection left

Assessed 27 July 2026 · Evidence as of 27 July 2026

Not much stands between this business and its pressures.

On the recordSince 27 July 2026 · Checkable from Q4 2026 · Every call on the record Checkpoint: Whether Incandor lands a signed fintech customer, or BioCatch/Sardine ship a duress classifier first

The call

Incandor is a small team pitching a feature into a market where BioCatch, Sardine, and Feedzai already ship overlapping tools with years of bank data behind them.

Incandor makes software that spots fraud by watching how customers behave on their phones and computers, like typing speed and mouse movements. This idea is 15 years old and already has rich competitors like BioCatch and Sardine who have spent years collecting data from banks and have more money to spend. Incandor's special features, like catching someone under threat to transfer money, are just add-ons that don't force banks to abandon the incumbents, and the biggest advantage in this business is having the most behavioral data from the most banks, which the older players have already built up. The one thing that matters is whether Incandor can land a real paying customer with a signed contract by the end of 2026, because without that, it will look like a feature pitch rather than a real product that banks want to buy.

Why

AI pressure: Deepfake and bot-farm generation tools plus agentic fraud-ops AI. Generative AI makes fake behavior easier to fake, and agentic AI could automate the fraud-ops workflow Incandor sells into. Could AI do the core job? Yes, likely.

Bigger players: BioCatch. BioCatch already ships DeviceIQ and leads analyst rankings, with Sardine and Feedzai running the same consortium-data playbook. Could a giant copy it? Yes, easily.

What protects it. None confirmed yet: no named bank customer, no signed contract, no data flywheel beyond a two-person Stanford team's claims.

What would change this call

BioCatch or Sardine ships a duress or coercion detection feature by Q4 2026. Would show incumbents can copy Incandor's differentiator faster than it can build a moat.
Incandor announces a priced seed round or named investors beyond Y Combinator by Q4 2026. Would show outside investors see durable traction beyond the YC launch.
Incandor discloses a named customer logo with a signed contract by Q4 2026. Would show its pilot conversations are converting into real revenue and product-market fit.

Key numbers

YC fintech deal volume fell 38.6% year over year (2026-04-15)
Incandor claims >99% account takeover accuracy, unaudited (2026-05)
BioCatch ranked top spot, SPARK Matrix behavioral biometrics (2026-06-30)

Named risks

No named customers or revenue confirmed as of May 2026 launch, pure vendor-marketing stage. Severity: high
Incumbents like BioCatch and Sardine can feature-chase duress detection faster than Incandor can build a data moat. Severity: high
Tightening fintech funding environment (YC deal volume down 38.6% YoY in Q1 2026) limits follow-on capital. Severity: medium
Generative AI (deepfakes, bots) can spoof behavioral biometrics, undermining core detection method. Severity: medium
No confirmed founder fraud-domain credibility or bank distribution relationships beyond Stanford background. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
BioCatch	losing to	Analyst-ranked SPARK Matrix leader with shipped DeviceIQ (2025) versus Incandor's unverified pre-seed claims as of May 2026
Sardine	losing to	Already markets composable device/behavior intelligence blocks, matching Incandor's stated differentiator, as of mid-2026
Feedzai	losing to	Established ML-driven behavioral fraud platform with consortium data scale Incandor lacks at pre-seed stage
Featurespace	losing to	Runs ARIC Risk Hub with behavioral/device features overlapping Incandor's roadmap as of 2026

Questions people ask

Is Incandor profitable?: No revenue or profitability data exists for Incandor. It is a pre-seed YC Winter 2026 (P26) startup with no disclosed pricing model, no named customers, and no independent revenue figures as of its May 2026 public launch.
Who are Incandor's biggest competitors?: BioCatch, Sardine, Feedzai, Featurespace, SEON and Sift all offer overlapping behavioral biometrics or device intelligence for fraud detection. BioCatch was ranked a leader in QKS Group's SPARK Matrix and shipped DeviceIQ in 2025, well ahead of Incandor's May 2026 launch.
Could AI replace Incandor's product?: Not directly, since behavioral telemetry itself is not AI-replaceable, but generative AI (deepfakes, browser automation, bot farms) actively spoofs behavioral biometrics, and agentic AI, per EY's July 2026 report, threatens to commoditize the downstream fraud-ops workflow Incandor targets.
Who owns Incandor?: Incandor is privately founder-owned, co-founded by two Stanford graduates, Matthew Yekell and a co-founder known as Luc, backed by Y Combinator (Winter 2026 batch, P26). No external VC investors or valuation have been publicly disclosed as of the May 2026 launch.
Does Incandor have any paying customers?: No named customer logos, contracts, or revenue signals have been publicly reported. The company's YC launch describes targeting Chief Risk Officers and CTOs at Series A-E fintechs, suggesting it is still in early outbound sales as of May 2026.
What makes Incandor different from BioCatch or Sardine?: Incandor claims a composable, programmable API, label-free cold-start detection using unsupervised clustering, and duress/coercion detection for coerced transactions. These are feature-level claims, unverified by third parties, versus incumbents with 15 years of consortium data accumulation.

Timeline

2026-07-09EY publishes report on agentic AI transforming fraud risk management workflows
2026-06-30BioCatch takes top spot in QKS Group SPARK Matrix for behavioral biometrics, DeviceIQ noted as 2025 launch
2026-05-21Incandor publicly launches via Y Combinator, part of Winter 2026 (P26) batch
2026-04-15YC fintech deal volume reported down 38.6% year-over-year for Q1 2026
2025BioCatch ships DeviceIQ for persistent device and cross-channel recognition

Revision history

27 July 2026

First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.

In the same band

Kinect RentAHuman Aster